Cargando…

Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome

We treated a 65-year-old man for COVID-19 who was hospitalized urgently due to life-threatening respiratory decompensation and later developed cardiac arrest, both of which were successfully treated. Three days prior to the patient's urgent hospitalization, he had a high fever of over 38.0°C. V...

Descripción completa

Detalles Bibliográficos
Autores principales: Konishi, Kazuhisa, Kuwahara, Hiroomi, Fujimoto, Yasuko, Nagata, Kazuhiro, Takeda, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039762/
https://www.ncbi.nlm.nih.gov/pubmed/36974237
http://dx.doi.org/10.7759/cureus.35290
_version_ 1784912336944889856
author Konishi, Kazuhisa
Kuwahara, Hiroomi
Fujimoto, Yasuko
Nagata, Kazuhiro
Takeda, Jun
author_facet Konishi, Kazuhisa
Kuwahara, Hiroomi
Fujimoto, Yasuko
Nagata, Kazuhiro
Takeda, Jun
author_sort Konishi, Kazuhisa
collection PubMed
description We treated a 65-year-old man for COVID-19 who was hospitalized urgently due to life-threatening respiratory decompensation and later developed cardiac arrest, both of which were successfully treated. Three days prior to the patient's urgent hospitalization, he had a high fever of over 38.0°C. Viral infection was diagnosed by polymerase chain reaction (PCR) on the day of admission, which was negative on the 11th day. Blood analysis on the second day was strongly positive for COVID-19 IgG antibodies, which continued for one year. Because of the acute increase in viral IgG antibodies, we performed other immunological analyses; Sjögren's syndrome antigen A (SS-A) and Sjögren's syndrome antigen B (SS-B) antibodies were positive, although he had no history of autoimmune diseases. Subsequent salivary-gland biopsy and pathological analysis confirmed the diagnosis of Sjögren’s syndrome. The severe clinical manifestations and early antibody seroconversion in this case suggest COVID-19 as a mediator of autoimmunity and Sjögren’s syndrome.
format Online
Article
Text
id pubmed-10039762
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-100397622023-03-26 Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome Konishi, Kazuhisa Kuwahara, Hiroomi Fujimoto, Yasuko Nagata, Kazuhiro Takeda, Jun Cureus Emergency Medicine We treated a 65-year-old man for COVID-19 who was hospitalized urgently due to life-threatening respiratory decompensation and later developed cardiac arrest, both of which were successfully treated. Three days prior to the patient's urgent hospitalization, he had a high fever of over 38.0°C. Viral infection was diagnosed by polymerase chain reaction (PCR) on the day of admission, which was negative on the 11th day. Blood analysis on the second day was strongly positive for COVID-19 IgG antibodies, which continued for one year. Because of the acute increase in viral IgG antibodies, we performed other immunological analyses; Sjögren's syndrome antigen A (SS-A) and Sjögren's syndrome antigen B (SS-B) antibodies were positive, although he had no history of autoimmune diseases. Subsequent salivary-gland biopsy and pathological analysis confirmed the diagnosis of Sjögren’s syndrome. The severe clinical manifestations and early antibody seroconversion in this case suggest COVID-19 as a mediator of autoimmunity and Sjögren’s syndrome. Cureus 2023-02-22 /pmc/articles/PMC10039762/ /pubmed/36974237 http://dx.doi.org/10.7759/cureus.35290 Text en Copyright © 2023, Konishi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Konishi, Kazuhisa
Kuwahara, Hiroomi
Fujimoto, Yasuko
Nagata, Kazuhiro
Takeda, Jun
Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome
title Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome
title_full Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome
title_fullStr Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome
title_full_unstemmed Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome
title_short Severe COVID-19 as a Possible Mediator of Autoimmunity and Sjögren’s Syndrome
title_sort severe covid-19 as a possible mediator of autoimmunity and sjögren’s syndrome
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039762/
https://www.ncbi.nlm.nih.gov/pubmed/36974237
http://dx.doi.org/10.7759/cureus.35290
work_keys_str_mv AT konishikazuhisa severecovid19asapossiblemediatorofautoimmunityandsjogrenssyndrome
AT kuwaharahiroomi severecovid19asapossiblemediatorofautoimmunityandsjogrenssyndrome
AT fujimotoyasuko severecovid19asapossiblemediatorofautoimmunityandsjogrenssyndrome
AT nagatakazuhiro severecovid19asapossiblemediatorofautoimmunityandsjogrenssyndrome
AT takedajun severecovid19asapossiblemediatorofautoimmunityandsjogrenssyndrome